Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD
Aliment Pharmacol Ther
.
2024 Jun;59(12):1644-1645.
doi: 10.1111/apt.18027.
Epub 2024 May 10.
Authors
Rupert W Leong
1
2
3
4
,
Vipul Jairath
5
,
Christopher Ma
6
Affiliations
1
Department of Gastroenterology and Hepatology, Concord Repatriation General Hospital, Sydney, New South Wales, Australia.
2
Concord Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
3
Department of Gastroenterology, Macquarie University Hospital, Sydney, New South Wales, Australia.
4
MQ Health, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia.
5
Division of Gastroenterology, Department of Medicine, Western University, London, Ontario, Canada.
6
Division of Gastroenterology & Hepatology, Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
PMID:
38726810
DOI:
10.1111/apt.18027
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Inflammatory Bowel Diseases*
Intestinal Barrier Function
Intestinal Mucosa / metabolism
Permeability